SCM
AMPE

Stevens Capital Management’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Stevens Capital Management’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-43
Closed -$46K – 1287
2014
Q3 		$46K Sell
43
-78
-64% -$131K ﹤0.01% 962
2014
Q2 		$302K Buy
+121
New +$247K 0.01% 811

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stevens Capital Management's AMPE Position: Q4 2014 in Review

Stevens Capital Management sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q4 2014, closing a stake of 43 shares — an estimated $46K sold.

Stevens Capital Management first reported a position in AMPE in Q2 2014 and held it in 2 quarters. The position peaked at $302K in Q2 2014. 69 funds tracked by Wall St. Rank hold AMPE as of Q4 2014.

  • Stevens Capital Management reported no remaining Ampio Pharmaceuticals Inc. position as of Q4 2014 after selling out during the quarter.
  • Stevens Capital Management sold 43 Ampio Pharmaceuticals Inc. shares in Q4 2014, an estimated $46K.
  • Stevens Capital Management first reported a position in Ampio Pharmaceuticals Inc. in Q2 2014 and held it in 2 quarters.
  • Stevens Capital Management's Ampio Pharmaceuticals Inc. position peaked at $302K in Q2 2014.
  • 69 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q4 2014.

Based on Stevens Capital Management's 13F filing for Q4 2014, filed 10 Feb 2015.